Mannose

glucosylceramidase beta ; Homo sapiens







14 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 30822514 Production of recombinant human acid β-glucosidase with high mannose-type N-glycans in rice gnt1 mutant for potential treatment of Gaucher disease. 2019 Jun 1
2 28207759 Investigations on therapeutic glucocerebrosidases through paired detection with fluorescent activity-based probes. 2017 1
3 23980545 Glycosylation and functionality of recombinant β-glucocerebrosidase from various production systems. 2013 Sep 25 1
4 21209725 Gaucher disease: clinical profile and therapeutic developments. 2010 Dec 6 1
5 19255873 Different dose-dependent correction of MIP-1beta and chitotriosidase during initial enzyme replacement therapy. 2009 Apr 1
6 15714077 Individualization of long-term enzyme replacement therapy for Gaucher disease. 2005 Feb 1
7 14605497 The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: a position statement. 2003 1
8 18020553 Alglucerase: practical guidance on appropriate dosage and administration in patients with Gaucher disease. 1998 Jan 1
9 8825806 Turnover and distribution of intravenously administered mannose-terminated human acid beta-glucosidase in murine and human tissues. 1996 Feb 1
10 8878985 The entrapment of mannose-terminated glucocerebrosidase (Alglucerase) in human carrier erythrocytes. 1996 Aug 1
11 7985893 Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources. 1995 Jan 1 1
12 8529110 Failure of alglucerase infused into Gaucher disease patients to localize in marrow macrophages. 1995 Mar 1
13 8486762 Binding, internalization, and degradation of mannose-terminated glucocerebrosidase by macrophages. 1993 May 5
14 1379912 Alglucerase. A review of its therapeutic use in Gaucher's disease. 1992 Jul 1